Medtronic PLC (MDT)
83.66
+0.09
(+0.11%)
USD |
NYSE |
Mar 18, 16:00
82.81
-0.85
(-1.02%)
Pre-Market: 05:08
Medtronic Enterprise Value: 128.09B for March 18, 2024
Enterprise Value Chart
Historical Enterprise Value Data
Date | Value |
---|---|
March 18, 2024 | 128.09B |
March 15, 2024 | 127.98B |
March 14, 2024 | 129.06B |
March 13, 2024 | 129.98B |
March 12, 2024 | 130.86B |
March 11, 2024 | 130.54B |
March 08, 2024 | 130.05B |
March 07, 2024 | 130.07B |
March 06, 2024 | 130.60B |
March 05, 2024 | 129.34B |
March 04, 2024 | 129.95B |
March 01, 2024 | 128.01B |
February 29, 2024 | 127.70B |
February 28, 2024 | 127.70B |
February 27, 2024 | 128.33B |
February 26, 2024 | 128.11B |
February 23, 2024 | 130.76B |
February 22, 2024 | 129.95B |
February 21, 2024 | 131.07B |
February 20, 2024 | 131.16B |
February 16, 2024 | 129.26B |
February 15, 2024 | 129.66B |
February 14, 2024 | 128.27B |
February 13, 2024 | 128.15B |
February 12, 2024 | 130.12B |
Date | Value |
---|---|
February 09, 2024 | 130.02B |
February 08, 2024 | 131.60B |
February 07, 2024 | 132.90B |
February 06, 2024 | 133.67B |
February 05, 2024 | 132.36B |
February 02, 2024 | 133.53B |
February 01, 2024 | 134.14B |
January 31, 2024 | 133.41B |
January 30, 2024 | 133.12B |
January 29, 2024 | 133.74B |
January 26, 2024 | 132.55B |
January 25, 2024 | 131.55B |
January 24, 2024 | 130.13B |
January 23, 2024 | 132.28B |
January 22, 2024 | 132.45B |
January 19, 2024 | 132.48B |
January 18, 2024 | 132.21B |
January 17, 2024 | 131.89B |
January 16, 2024 | 132.55B |
January 12, 2024 | 133.72B |
January 11, 2024 | 133.28B |
January 10, 2024 | 133.26B |
January 09, 2024 | 132.70B |
January 08, 2024 | 132.59B |
January 05, 2024 | 129.93B |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
109.59B
Minimum
Oct 27 2023
197.40B
Maximum
Sep 08 2021
149.41B
Average
148.12B
Median
Enterprise Value Benchmarks
Boston Scientific Corp | 107.13B |
Stryker Corp | 144.59B |
Abbott Laboratories | 202.73B |
Axonics Inc | 3.136B |
Reshape Lifesciences Inc | 0.7013M |
Enterprise Value Related Metrics
Net Income (Quarterly) | 1.322B |
Revenue (Quarterly) | 8.089B |
Total Expenses (Quarterly) | 6.586B |
EPS Diluted (Quarterly) | 0.99 |
Gross Profit Margin (Quarterly) | 65.61% |
Profit Margin (Quarterly) | 16.34% |
Earnings Yield | 3.75% |
Operating Earnings Yield | 5.51% |
Normalized Earnings Yield | 4.073 |